CAS 1041053-44-4 1-(1,3-Oxazol-2-yl)methanamine hydrochloride (HCID 46912060)

기본 정보

CAS: 1041053-44-4
표준 SMILES: Cl.NCc1ncco1
InChIKey: YMJMSYXLHSSGTP-UHFFFAOYSA-N
분자식: C4H7ClN2O
평균 분자량: 134.56 g/mol

이름 및 식별자

우선 이름: 1-(1,3-Oxazol-2-yl)methanamine hydrochloride
IUPAC: 1,3-oxazol-2-ylmethanamine;hydrochloride
현지명: 옥사졸-2-일-메틸아민염산염
영어명: Oxazol-2-yl-MethylaMine hydrochloride
분자식: C4H6N2O.HCl
분자량: 134.56418

이름 및 동의어

1041053-44-41-(1,3-oxazol-2-yl)methanamine hydrochlorideRefChem:419400807-295-2Oxazol-2-ylmethanamine hydrochloride907544-38-1OXAZOL-2-YL-METHYLAMINE HYDROCHLORIDEOxazol-2-ylmethanamine xhydrochloride1,3-oxazol-2-ylmethanamine;hydrochloride1,3-oxazol-2-ylmethanamine hydrochlorideMFCD067389292-Oxazolemethanamine hydrochloride

이름 더 보기

옥사졸-2-일-메틸아민염산염2-(Aminomethyl)-1,3-oxazolehydrochloride

Oxazol-2-ylmethylamine hydrochlorideOxazol-2-ylmethanaminehydrochlorideDS-14629EN300-1604857(OXAZOL-2-YL)METHANAMINE HYDROCHLORIDE2-(Aminomethyl)oxazole hydrochlorideOXAZOL-2-YLMETHYLAMINE HCLBCP16393

데이터베이스 식별자

CAS: 1041053-44-4
PubChem CID: 46912060
EC Number: 807-295-2

물성

구조 계산 물성

극성 표면적: 52.1 Å²
수소 결합 공여자 수: 2
수소 결합 수용자 수: 3
회전 가능 결합 수: 1
무거운 원자 수: 8
형식 전하: 0
복잡도: 57.7

물리화학적 성질

저장 조건: Store at room temperature

안전 및 규제

GHS 분류

GHS Classification · 4건

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesSkin Irrit. 2 (100%)

안전 데이터

HS 번호: 2922390090

화학 및 산업

응용 분야 · 1건

용도Oxazol-2-ylmethanamine Hydrochloride acts as a reagent for the preparation of dihydropyrimidino-isoquinolinones as GPR84 inhibitors useful in the treatment of inflammatory disorders, preparation of thiazole derivatives as ERR-α inverse agonists useful in the treatment of cancer